Community-owned database empowers individuals with cryptocurrency for contributing genomic data SAN DIEGO — Luna DNA, the first and only genomic and medical research knowledge base powered by the blockchain and owned by its community, announced $2 Million in Seed funding today. The round included several individual investors and former executives from Illumina ILMN 0.34%, the world leader in DNA sequencing and […]

Spectris plc (‘Spectris’) (LSE: SXS), the productivity-enhancing instrumentation and controls company, today announces that it has signed an agreement with Macquarie Capital, the corporate advisory and principal investment arm of Macquarie Group, for them to acquire 50% of Spectris’ environmental monitoring business EMS Brüel & Kjær (‘EMS B&K’) for a total cash consideration of AUD76.6 million […]

New York, NY - Schrödinger, Inc., a privately-held company dedicated to revolutionizing drug discovery through advanced computational methods, announced today that it has received a payment from Sanofi for reaching a major milestone in its multi-year, multi-target drug discovery collaboration. The project in which the milestone was achieved is one of several programs that Schrödinger is […]

The facility will address increasing demand for small-volume mAb CDMO services Lyon, France – Novasep, a leading supplier of services and technologies for the life sciences industry, announces a €17M investment in a dedicated GMP mAb production facility. The facility will be located in Pompey (FR) and will be operational by mid-2019. The investment, part of […]

APIX Analytics, a leading supplier of next generation miniaturized gas analyzers, announced today a series B investment of almost 8 million euros from its historical investors and two new investors.  Both the Ecotechnologies fund, managed by Bpifrance, and BNP Paribas Développement fund joined Demeter Ventures (formerly EMERTEC Gestion), ALIAD (Air Liquide), Kreaxi, ENGIE New Ventures, […]

San Diego, CA – Agena Bioscience, a global provider of molecular genetic solutions, today announced it has been selected to participate as an innovative technology provider in the ‘Liquid biopsies and IMAging for improved cancer care’ (LIMA) project. The LIMA project has been awarded a EUR 6.3 million Horizon 2020 European Union research grant to […]

PARIS Aenitis Technologies, which develops new medical equipment based on acoustic manipulation of biological particles, today announced that it has received €4 million in funding, following its application to the highly-selective SME Instrument Phase 2 European programme, in the “Healthcare Biotechnology” category. SME Instrument Phase 2 is part of Horizon 2020, a programme managed by […]

Accelerates growth in cell analysis, new technology and market development PEARLAND, Texas–Base Pair Biotechnologies, Inc., The Aptamer Discovery Company™, today announced the completion of its $3.2 Million Series A-3 financing round and the opening of its new 5,000 square foot laboratory and office facility in Pearland, TX, a Houston suburb. Toronto-based Eventi Capital Partners Inc. […]

SAN DIEGO, CA — NanoCellect Biomedical Inc., a developer of microfluidic cell sorting technologies for cell based assays, today announced the completion of a $10 million Series B financing round, including convertible notes. The financing included the participation of new investors Illumina Ventures, Anzu Partners, Vertical Venture Partners, and 5 Prime Ventures. Also participating in […]